Cargando…

Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center

BACKGROUND: Increasing reports suggest the safe use of direct oral anticoagulants (DOACs) in electrical cardioversion. The aim of this study was to assess the trends and 30-day outcomes associated with anticoagulation for cardioversion. METHODS: Patients who underwent electrical cardioversion from J...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arshad, Samiullah, Davis, George A., Amir, Muhammad, Goldberg, Ythan H., Gupta, Vedant A., Abdel-Latif, Ahmed K., Smyth, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993439/ https://www.ncbi.nlm.nih.gov/pubmed/35465085 http://dx.doi.org/10.14740/cr1352

Ejemplares similares

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
por: Mentias, Amgad, et al.
Publicado: (2021)

Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter
por: Wall, Christopher, et al.
Publicado: (2019)

Ibutilide for pharmacological cardioversion of atrial flutter
por: Magnusson, K, et al.
Publicado: (2002)

Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter
por: Malviya, Amit, et al.
Publicado: (2020)

DC cardioversion of atrial fibrillation and atrial flutter in the emergency department: improving specialist protocols for the generalist
por: Carpenter, Alexander, et al.
Publicado: (2018)

Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation
por: Wybraniec, Maciej T., et al.
Publicado: (2023)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Recurrent Atrial Flutter Requiring Multiple Cardioversions in a Preterm Infant
por: Jaile, Jesus C., et al.
Publicado: (2021)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021)

Prolonged asystole following direct-current cardioversion for atrial flutter.
por: McMullan, R., et al.
Publicado: (2001)

Tolerance of High-Dose Oral Amiodarone for Cardioversion of Atrial Flutter
por: Le, Vincent K., et al.
Publicado: (2022)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Croatia needs a registry of patients undergoing direct current cardioversion for persistent atrial fibrillation/flutter
por: Dubravčić, Mia, et al.
Publicado: (2016)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?
por: Naydenov, Stefan, et al.
Publicado: (2021)

Do we always need anticoagulation before cardioversion of atrial fibrillation in ladies?
por: Görenek, Bülent, et al.
Publicado: (2016)

Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials
por: Thind, Munveer, et al.
Publicado: (2020)

Cardioversion of Atrial Arrhythmias: Audit of Anticoagulation Management
por: Mayet, Jamil, et al.
Publicado: (1997)

A stepwise external cardioversion protocol for atrial fibrillation to maximize acute success rate
por: Darrat, Yousef, et al.
Publicado: (2023)

Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis
por: Shin, Dong Geum, et al.
Publicado: (2015)

Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry
por: Kapłon-Cieślicka, Agnieszka, et al.
Publicado: (2022)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

Successful treatment of neonatal atrial flutter by synchronized cardioversion: case report and literature review
por: Wójtowicz-Marzec, Monika, et al.
Publicado: (2020)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion
por: Barysienė, Jūratė, et al.
Publicado: (2017)

Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results
por: Goldenthal, Isaac L., et al.
Publicado: (2019)

Current Status of Internal Cardioversion in Atrial Fibrillation
por: Plewan, Andreas, et al.
Publicado: (2002)

Ogilvie's Syndrome following Cardioversion for Atrial Fibrillation
por: Al-Halawani, Moh'd, et al.
Publicado: (2014)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Timing of cardioversion in atrial fibrillation: the sooner the better?
por: Capranzano, Piera, et al.
Publicado: (2020)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study
por: Kim, Yun Gi, et al.
Publicado: (2018)

The Comparative Effectiveness and Safety of Different Anticoagulation Strategies for Treatment of Left Atrial Appendage Thrombus in the Setting of Chronic Anticoagulation for Atrial Fibrillation or Flutter
por: Kołakowski, Karol, et al.
Publicado: (2021)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
por: Walsh, Simon J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ae3ahojl4l6ucsok1e6g4tgusf